Setting realistic expectations is crucial: improvement rather than total cure is the typical outcome
For the vial you actually receive, we issue a batch-specific COA identifying compound, CAS number, lot, manufacture date, purity, and HPLC methodology
[1] [2] This enzyme belongs to the family of oxidoreductases, specifically those acting on a sulfur group of donors with a quinone or similar compound as acceptor
IV infusions cost between 890 to 1290 per infusion per week, adding up to over 50,000 AUD per year
Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine beta-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer